PHVS
Pharvaris BV
31.10$
-1.8%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +13.0% | +3.2% | – | – | +1.2% | +4.1% | – | – | -2.8% | – | – | – | – | – | – | – | +71.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +55.9% | +0.0% | +0.0% | +97.1% | -14.2% | +80.2% | +16.9% | +52.3% | +4.7% | -0.1% | +11.1% | +19.5% | +26.3% | +8.1% | -2.9% | +13.2% | -8.1% | +8.4% | +16.0% | +0.4% | -0.5% | +24.6% | +11.8% | +21.0% | -0.9% | -4.2% | +0.7% | +14.5% | -10.2% | +14.2% | – | |
| – | +0.0% | +0.0% | +0.0% | +248.1% | +0.0% | +0.0% | +57.5% | -8.0% | +65.4% | -13.1% | +69.4% | +83.9% | +23.7% | -6.2% | +20.3% | +11.4% | +30.6% | +8.3% | -9.4% | -2.5% | -94.0% | +1,634.9% | +11.8% | +14.4% | +15.5% | +7.1% | +14.6% | -18.9% | -4.5% | -8.5% | +36.6% | +0.0% | +17.3% | – | |
| – | – | – | – | – | – | – | – | -14.9% | +76.4% | +9.6% | +55.6% | +21.3% | +7.4% | +4.8% | +21.8% | +19.3% | +17.2% | -1.0% | +4.7% | -4.3% | +8.1% | +7.5% | +3.7% | +4.2% | +21.4% | +10.2% | +19.0% | -193.6% | – | -1.8% | +20.0% | -5.7% | +13.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -195.7% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | +0.4% | – | – | -25.8% | -21.6% | +236.7% | -93.5% | +206.2% | -71.5% | – | – | +44,204.4% | -99.6% | – | – | – | – | – | – | -16.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +4,342.4% | +0.0% | +0.0% | +206.9% | +136.0% | -35.6% | +541.6% | -165.9% | – | -84.0% | +2,199.8% | -128.8% | – | +7,435.2% | -183.0% | – | -78.5% | +57.5% | +42.7% | – | – | -75.2% | +225.8% | – | – | -33.0% | -189.5% | – | – | +116.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.